Boothbay Fund Management’s Pfizer PFE Stock Holding History

Boothbay Fund Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-94,600	Closed	-$2.65M	–	1849
2024 Q2	$2.65M	Buy	+94,600	New	+$2.6M	0.06%	416
2023 Q2	–	Sell	-142,500	Closed	-$5.81M	–	2185
2023 Q1	$5.81M	Buy	+142,500	New	+$6.15M	0.12%	207
2022 Q4	–	Sell	-20,300	Closed	-$888K	–	2352
2022 Q3	$888K	Buy	20,300 +5,500	+37%	+$267K	0.02%	935
2022 Q2	$776K	Sell	14,800 -13,800	-48%	-$703K	0.02%	944
2022 Q1	$1.48M	Sell	28,600 -1,305,800	-98%	-$67.8M	0.03%	723
2021 Q4	$78.8M	Buy	+1,334,400	New	+$66.1M	1.85%	4

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Boothbay Fund Management's PFE Position: Q2 2026 in Review

Boothbay Fund Management opened a new position in Pfizer (PFE) in Q2 2026: 194,734 shares worth $4.69M. The stake represents 0.06% of the portfolio and ranks #376 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in PFE as recently as Q4 2025.

Boothbay Fund Management first reported a position in PFE in Q4 2014 and has held it in 19 quarters since. The position peaked at $72.4M in Q4 2021. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Boothbay Fund Management held 194,734 shares of Pfizer worth $4.69M as of Q2 2026.
Pfizer was a new Boothbay Fund Management position in Q2 2026.
Pfizer made up 0.06% of Boothbay Fund Management's portfolio in Q2 2026, its #376 holding.
Boothbay Fund Management first reported a position in Pfizer in Q4 2014 and has held it in 19 quarters since.
Boothbay Fund Management's Pfizer position peaked at $72.4M in Q4 2021.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.